Replimune Group, Inc.

REPL · NasdaqGS

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

–

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders1.6%

Institutions104.2%

Public / Other

Income Statement

	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$261.63M	-$234.77M	-$177.08M	-$118.31M	-$79.95M	-$56.20M	-$30.95M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$247.30M	-$215.79M	-$174.28M	-$118.04M	-$80.87M	-$52.63M	-$30.83M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-3.07	$-3.24	$-2.99	$-2.26	$-1.75	$-1.54	$-1.33
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-3.07	$-3.24	$-2.99	–	–	–	–

Balance Sheet

	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31
Cash and highly liquid short-term investments the company can access almost immediately.	$111.12M	$74.46M	$146.59M	$105.95M	$182.52M	$59.50M	$25.70M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$551.33M	$487.72M	$646.59M	–	$543.10M	$234.10M	–
All of the company's interest-bearing borrowings, short and long term combined.	$46.38M	$44.81M	$28.65M	–	–	–	–
Everything the company owes — debt, unpaid bills, and other obligations.	$135.49M	$113.21M	$91.30M	–	$44.37M	$50.38M	–
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$415.84M	$374.51M	$555.29M	–	$498.73M	$183.72M	–

Cash Flow Statement

	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$192.25M	-$185.47M	-$128.05M	-$82.18M	-$61.39M	-$60.55M	-$25.38M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$6.69M	$5.66M	$2.27M	$2.34M	$2.39M	$6.54M	$2.60M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$198.94M	-$191.13M	-$130.32M	-$84.52M	-$63.78M	-$67.09M	-$27.98M

	You	Peer avg
Revenue Growth	–	+69.8%
ROE	-134.3%	-50.3%

Replimune Group, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison